Inhibition of hypothalamic inhibitor κ B kinase β/nuclear transcription factor κ B pathway attenuates metabolism and cardiac dysfunction in type 2 diabetic rats.
Inflammation and oxidative stressplay important roles in energy imbalance and its complications.Recent research indicates that hypothalamic inflammation may contribute to the pathogenesis of metabolic syndrome and cardiac dysfunction, but the mechanisms remain unclear. We hypothesized that suppression of proinflammatory pathway of IKKβ/NF-κBin the hypothalamuscan improve energy balance and cardiac function in type 2 diabetic (T2D)rats. Normal rats and T2D rats received bilateral hypothalamic arcuate nucleus (ARC) infusions of IKKβ inhibitor SC-514 or vehicle via osmotic minipump.Metabolic phenotyping, immunohistochemical analyses, and biochemical analyses were used to investigate the outcomes of inhibition of the hypothalamic IKKβ. Echocardiography and glucometer were used for measuring cardiac function and blood glucose,respectively. Blood samples were collected for the evaluation of circulating proinflammatory cytokines (PICs). Heart was harvested for cardiacmorphology evaluations. The ARC was harvested and analyzed for IKKβ, NF-κB, PICs, reactive oxygen species (ROS) and NAD(P)H (gp91phox,p47phox) oxidase activitylevels and neuropeptides.Compared with normal rats, T2D rats were characterized by hyperglycaemia, hyperinsulinemia, glucose intolerance, cardiac dysfunction, as well as higher ARC levels of IKKβ, NF-κB, PICs, ROS, gp91phox and p47phox. ARC infusion of IKKβ inhibitor SC-514 attenuated all these changes in T2D rats, but not in normal rats. Our results indicate that hypothalamic IKKβ/NF-κB pathway plays a key role in modulatingenergy imbalance and cardiac dysfunction, suggesting its potential therapeutic role during type 2diabetes.